Top

Journal of Cardiovascular Translational Research

Published in:

01-10-2013

Ultrasound Contrast Materials in Cardiovascular Medicine: from Perfusion Assessment to Molecular Imaging

Author: Alexander L. Klibanov

Published in: Journal of Cardiovascular Translational Research | Issue 5/2013

Abstract

Ultrasound imaging is widely used in cardiovascular diagnostics. Contrast agents expand the range of tasks that ultrasound can perform. In the clinic in the USA, endocardial border delineation and left ventricle opacification have been an approved indication for more than a decade. However, myocardial perfusion contrast ultrasound studies are still at the clinical trials stage. Blood pool contrast and perfusion in other tissues might be an easier indication to achieve: general blood pool ultrasound contrast is in wider use in Europe, Canada, Japan, and China. Targeted (molecular) contrast microbubbles will be the next generation of ultrasound imaging probes, capable of specific delineation of the areas of disease by adherence to molecular targets. The shell of targeted microbubbles (currently in the preclinical research and early stage clinical trials) is decorated with the ligands (antibodies, peptides or mimetics, hormones, and carbohydrates) that ensure firm binding to the molecular markers of disease.

Available only for authorised users

Gramiak, R., & Shah, P. M. (1968). Echocardiography of the aortic root. Investigative Radiology, 3(5), 356–366.PubMedCrossRef

Gramiak, R., & Shah, P. M. (1971). Detection of intracardiac blood flow by pulsed echo-ranging ultrasound. Radiology, 100(2), 415–418.PubMed

Schurmann, R., & Schlief, R. (1994). Saccharide-based contrast agents. Characteristics and diagnostic potential. La Radiologia Medica, 87(5 Suppl 1), 15–23.PubMed

Keller, M. W., Glasheen, W., & Kaul, S. (1989). Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. Journal of the American Society of Echocardiography, 2(1), 48–52.PubMed

Skyba, D. M., Camarano, G., Goodman, N. C., Price, R. J., Skalak, T. C., & Kaul, S. (1996). Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. Journal of the American College of Cardiology, 28(5), 1292–1300.PubMedCrossRef

Schneider, M., Arditi, M., Barrau, M. B., Brochot, J., Broillet, A., Ventrone, R., et al. (1995). BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Investigative Radiology, 30(8), 451–457.PubMedCrossRef

Grauer, S. E., Pantely, G. A., Xu, J., Ge, S., Giraud, G. D., Shiota, T., et al. (1996). Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: experimental studies in pigs. American Heart Journal, 132(5), 938–945.PubMedCrossRef

Wijkstra H., Smeenge M., Rosette Jdl. , Pochon S., Tardy-Cantalupi I., Tranquart F. (2012) Targeted microbubble prostate cancer imagign with BR55. In: Cate Ft, Jong Nd, Leen E (eds) The 17th European Symposium on Ultrasound Contrast Imaging., Rotterdam, p 6.

Leighton, T. G. (1994). The acoustic bubble. London: Academic Press.

10.

de Jong, N., Emmer, M., van Wamel, A., & Versluis, M. (2009). Ultrasonic characterization of ultrasound contrast agents. Medical and Biological Engineering and Computing, 47(8), 861–873.PubMedCrossRef

11.

Bouakaz, A., Versluis, M., & de Jong, N. (2005). High-speed optical observations of contrast agent destruction. Ultrasound in Medicine and Biology, 31(3), 391–399.PubMedCrossRef

12.

Phillips, P., & Gardner, E. (2004). Contrast-agent detection and quantification. European Radiology, 14(Suppl 8), P4–P10.PubMed

13.

Klibanov, A. L., Rasche, P. T., Hughes, M. S., Wojdyla, J. K., Galen, K. P., Wible, J. H., Jr., et al. (2004). Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Investigative Radiology, 39(3), 187–195.PubMedCrossRef

14.

Senior, R., Lepper, W., Pasquet, A., Chung, G., Hoffman, R., Vanoverschelde, J. L., et al. (2004). Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. American Heart Journal, 147(6), 1100–1105.PubMedCrossRef

15.

Dijkmans, P. A., Knaapen, P., Sieswerda, G. T., Aiazian, E., Visser, C. A., Lammertsma, A. A., et al. (2006). Quantification of myocardial perfusion using intravenous myocardial contrast echocardiography in healthy volunteers: comparison with positron emission tomography. Journal of the American Society of Echocardiography, 19(3), 285–293.PubMedCrossRef

16.

Wei, K., Jayaweera, A. R., Firoozan, S., Linka, A., Skyba, D. M., & Kaul, S. (1998). Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation, 97(5), 473–483.PubMedCrossRef

17.

Senior, R., Monaghan, M., Main, M. L., Zamorano, J. L., Tiemann, K., Agati, L., et al. (2009). Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two Phase 3 international trials in comparison with radionuclide perfusion imaging. European Journal of Echocardiography, 10(1), 26–35.PubMedCrossRef

18.

Wilson, S. R., Jang, H. J., Kim, T. K., Iijima, H., Kamiyama, N., & Burns, P. N. (2008). Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR. American Journal of Roentgenology, 190(3), 691–695.PubMedCrossRef

19.

Kalantarinia, K., Belcik, J. T., Patrie, J. T., & Wei, K. (2009). Real-time measurement of renal blood flow in healthy subjects using contrast-enhanced ultrasound. American Journal of Physiology. Renal Physiology, 297(4), F1129–F1134.PubMedCrossRef

20.

Staub, D., Patel, M. B., Tibrewala, A., Ludden, D., Johnson, M., Espinosa, P., et al. (2011). Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke, 41(1), 41–47.CrossRef

21.

Vavuranakis, M., Kakadiaris, I. A., O'Malley, S. M., Papaioannou, T. G., Sanidas, E. A., Naghavi, M., et al. (2008). A new method for assessment of plaque vulnerability based on vasa vasorum imaging, by using contrast-enhanced intravascular ultrasound and differential image analysis. International Journal of Cardiology, 130(1), 23–29.PubMedCrossRef

22.

Klibanov, A. L., Hughes, M. S., Marsh, J. N., Hall, C. S., Miller, J. G., Wible, J. H., et al. (1997). Targeting of ultrasound contrast material. An in vitro feasibility study. Acta Radiologica. Supplement, 412, 113–120.

23.

Pochon, S., Tardy, I., Bussat, P., Bettinger, T., Brochot, J., von Wronski, M., et al. (2010). BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Investigative Radiology, 45(2), 89–95.PubMedCrossRef

24.

Pelura, T. J., & Pelura, T. J. (1998). Clinical experience with AF0150 (Imagent US), a new ultrasound contrast agent. Academic Radiology, 1(5 Suppl), S69–S71. discussion S72-64.CrossRef

25.

Sugimoto, K., Moriyasu, F., Saito, K., Taira, J., Saguchi, T., Yoshimura, N., et al. (2012). Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading. Journal of Ultrasound in Medicine, 31(4), 529–538.PubMed

26.

Wible, J. H., Jr., Wojdyla, J. K., Bales, G. L., McMullen, W. N., Geiser, E. A., & Buss, D. D. (1996). Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs. Journal of the American Society of Echocardiography, 9(4), 442–451.PubMedCrossRef

27.

Klibanov, A. L., Hughes, M. S., Villanueva, F. S., Jankowski, R. J., Wagner, W. R., Wojdyla, J. K., et al. (1999). Targeting and ultrasound imaging of microbubble-based contrast agents. Magma, 8(3), 177–184.PubMed

28.

Takalkar, A. M., Klibanov, A. L., Rychak, J. J., Lindner, J. R., & Ley, K. (2004). Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. Journal of Controlled Release, 96(3), 473–482.PubMedCrossRef

29.

Klibanov, A. L., Rychak, J. J., Yang, W. C., Alikhani, S., Li, B., Acton, S., et al. (2006). Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media & Molecular Imaging, 1(6), 259–266.CrossRef

30.

Guenther, F., von zur Muhlen, C., Ferrante, E. A., Grundmann, S., Bode, C., & Klibanov, A. L. (2010). An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions. Investigative Radiology, 45(10), 586–591.PubMedCrossRef

31.

Rychak, J. J., Li, B., Acton, S. T., Leppanen, A., Cummings, R. D., Ley, K., et al. (2006). Selectin ligands promote ultrasound contrast agent adhesion under shear flow. Molecular Pharmaceutics, 3(5), 516–524.PubMedCrossRef

32.

Kim, D. H., Klibanov, A. L., & Needham, D. (2000). The influence of tiered layers of surface-grafted poly(ethylene glycol) on receptor–ligand-mediated adhesion between phospholipid monolayer-stabilized microbubbles and coated glass beads. Langmuir, 16(6), 2808–2817.CrossRef

33.

Ham, A. S., Klibanov, A. L., & Lawrence, M. B. (2009). Action at a distance: lengthening adhesion bonds with poly(ethylene glycol) spacers enhances mechanically stressed affinity for improved vascular targeting of microparticles. Langmuir, 25(17), 10038–10044.PubMedCrossRef

34.

Rychak, J. J., Lindner, J. R., Ley, K., & Klibanov, A. L. (2006). Deformable gas-filled microbubbles targeted to P-selectin. Journal of Controlled Release, 114(3), 288–299.PubMedCrossRef

35.

Ferrante, E. A., Pickard, J. E., Rychak, J., Klibanov, A., & Ley, K. (2009). Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. Journal of Controlled Release, 140(2), 100–107.PubMedCrossRef

36.

Maul, T. M., Dudgeon, D. D., Beste, M. T., Hammer, D. A., Lazo, J. S., Villanueva, F. S., et al. (2010). Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength. Biotechnology and Bioengineering, 107(5), 854–864.PubMedCrossRef

37.

Fadok, V. A., de Cathelineau, A., Daleke, D. L., Henson, P. M., & Bratton, D. L. (2001). Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. The Journal of Biological Chemistry, 276(2), 1071–1077.PubMedCrossRef

38.

Yanagisawa, K., Moriyasu, F., Miyahara, T., Yuki, M., & Iijima, H. (2007). Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound in Medicine and Biology, 33(2), 318–325.PubMedCrossRef

39.

Lindner, J. R., Song, J., Xu, F., Klibanov, A. L., Singbartl, K., Ley, K., et al. (2000). Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation, 102(22), 2745–2750.PubMedCrossRef

40.

Christiansen, J. P., Leong-Poi, H., Klibanov, A. L., Kaul, S., & Lindner, J. R. (2002). Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation, 105(15), 1764–1767.PubMedCrossRef

41.

Villanueva, F. S., Jankowski, R. J., Klibanov, S., Pina, M. L., Alber, S. M., Watkins, S. C., et al. (1998). Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation, 98(1), 1–5.PubMedCrossRef

42.

Kaufmann, B. A., Sanders, J. M., Davis, C., Xie, A., Aldred, P., Sarembock, I. J., et al. (2007). Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation, 116(3), 276–284.PubMedCrossRef

43.

Lindner, J. R., Song, J., Christiansen, J., Klibanov, A. L., Xu, F., & Ley, K. (2001). Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation, 104(17), 2107–2112.PubMedCrossRef

44.

Davidson, B. P., Kaufmann, B. A., Belcik, J. T., Xie, A., Qi, Y., & Lindner, J. R. (2012). Detection of antecedent myocardial ischemia with multiselectin molecular imaging. Journal of the American College of Cardiology, 60(17), 1690–1697.PubMedCrossRef

45.

Myrset, A. H., Fjerdingstad, H. B., Bendiksen, R., Arbo, B. E., Bjerke, R. M., Johansen, J. H., et al. (2011). Design and characterization of targeted ultrasound microbubbles for diagnostic use. Ultrasound in Medicine and Biology, 37(1), 136–150.PubMedCrossRef

46.

Hust, M., Frenzel, A., Meyer, T., Schirrmann, T., & Dubel, S. (2012). Construction of human naive antibody gene libraries. Methods in Molecular Biology, 907, 85–107.PubMed

47.

Hernot, S., Unnikrishnan, S., Du, Z., Shevchenko, T., Cosyns, B., Broisat, A., et al. (2012). Nanobody-coupled microbubbles as novel molecular tracer. Journal of Controlled Release, 158(2), 346–353.PubMedCrossRef

48.

Feldwisch, J., & Tolmachev, V. (2012). Engineering of affibody molecules for therapy and diagnostics. Methods in Molecular Biology, 899, 103–126.PubMedCrossRef

49.

Hayat, S. A., & Senior, R. (2008). Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? European Heart Journal, 29(3), 299–314.PubMedCrossRef

50.

Villanueva, F. S., Lu, E., Bowry, S., Kilic, S., Tom, E., Wang, J., et al. (2007). Myocardial ischemic memory imaging with molecular echocardiography. Circulation, 115(3), 345–352.PubMedCrossRef

51.

Weller, G. E., Lu, E., Csikari, M. M., Klibanov, A. L., Fischer, D., Wagner, W. R., et al. (2003). Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation, 108(2), 218–224.PubMedCrossRef

52.

Wang, X., Hagemeyer, C. E., Hohmann, J. D., Leitner, E., Armstrong, P. C., Jia, F., et al. (2012). Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation, 125(25), 3117–3126.PubMedCrossRef

53.

Unger, E. C., McCreery, T. P., Sweitzer, R. H., Shen, D., & Wu, G. (1998). In vitro studies of a new thrombus-specific ultrasound contrast agent. The American Journal of Cardiology, 81(12A), 58G–61G.PubMedCrossRef

54.

Korosoglou, G., Behrens, S., Bekeredjian, R., Hardt, S., Hagenmueller, M., Dinjus, E., et al. (2006). The potential of a new stable ultrasound contrast agent for site-specific targeting. An in vitro experiment. Ultrasound Medicine Biology, 32(10), 1473–1478.CrossRef

55.

Lindner, J. R. (2002). Detection of inflamed plaques with contrast ultrasound. The American Journal of Cardiology, 90(10C), 32L–35L.PubMedCrossRef

56.

Wu, J., Leong-Poi, H., Bin, J., Yang, L., Liao, Y., Liu, Y., et al. (2011). Efficacy of contrast-enhanced US and magnetic microbubbles targeted to vascular cell adhesion molecule-1 for molecular imaging of atherosclerosis. Radiology, 260(2), 463–471.PubMedCrossRef

57.

Anastasianides P., Mojica K., Matter M. L., Allen J. S. (http://www.acoustics.org/press/157th/anastasiadis.html) Targeted ultrasound contrast agents for the imaging of biofilm infections. Accessed 2013.05.26

58.

Dong, Y., Chen, S., Wang, Z., Peng, N., & Yu, J. (2013). Synergy of ultrasound microbubbles and vancomycin against Staphylococcus epidermidis biofilm. The Journal of Antimicrobial Chemotherapy, 68(4), 816–826.PubMedCrossRef

59.

Christiansen, J. P., French, B. A., Klibanov, A. L., Kaul, S., & Lindner, J. R. (2003). Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound in Medicine and Biology, 29(12), 1759–1767.PubMedCrossRef

60.

Leong-Poi, H., Kuliszewski, M. A., Lekas, M., Sibbald, M., Teichert-Kuliszewska, K., Klibanov, A. L., et al. (2007). Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circulation Research, 101(3), 295–303.PubMedCrossRef

61.

Vannan, M., McCreery, T., Li, P., Han, Z., Unger, E., Kuersten, B., et al. (2002). Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. Journal of the American Society of Echocardiography, 15(3), 214–218.PubMedCrossRef

62.

Carson, A. R., McTiernan, C. F., Lavery, L., Grata, M., Leng, X., Wang, J., et al. (2012). Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Research, 72(23), 6191–6199.PubMedCrossRef

63.

Wu, Y., Unger, E. C., McCreery, T. P., Sweitzer, R. H., Shen, D., Wu, G., et al. (1998). Binding and lysing of blood clots using MRX-408. Investigative Radiology, 33(12), 880–885.PubMedCrossRef

64.

Alexandrov, A. V. (2006). Ultrasound enhanced thrombolysis for stroke. International Journal of Stroke, 1(1), 26–29.PubMedCrossRef

65.

Hynynen, K., McDannold, N., Vykhodtseva, N., Raymond, S., Weissleder, R., Jolesz, F. A., et al. (2006). Focal disruption of the blood–brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. Journal of Neurosurgery, 105(3), 445–454.PubMedCrossRef

Title: Ultrasound Contrast Materials in Cardiovascular Medicine: from Perfusion Assessment to Molecular Imaging
Author: Alexander L. Klibanov
Publication date: 01-10-2013
Publisher: Springer US
Published in: Journal of Cardiovascular Translational Research / Issue 5/2013
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-013-9501-0

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ultrasound Contrast Materials in Cardiovascular Medicine: from Perfusion Assessment to Molecular Imaging

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2013

CXCR4+ and FLK-1+ Identify Circulating Cells Associated with Improved Cardiac Function in Patients Following Myocardial Infarction

Diagnosing and Characterizing Coronary Artery Disease in Women: Developments in Noninvasive and Invasive Imaging Techniques

Biological Imaging of Atherosclerosis: Moving Beyond Anatomy

Myocardial Perfusion Imaging with Cardiac Computed Tomography: State of the Art

Computed Fractional Flow Reserve (FFTCT) Derived from Coronary CT Angiography

Association of Genetic Variation with Gene Expression and Protein Abundance within the Natriuretic Peptide Pathway

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page